Utah Retirement Systems Alkermes Plc. Transaction History

Utah Retirement Systems

9 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q1 2020 May 15, 2020	SELL	$13.06 - $21.24 $388,025 - $631,061	-29,711 Closed	0 $0
Q4 2019 Feb 12, 2020	BUY	$17.29 - $21.74 $3,458 - $4,348	200 Added 0.68%	29,711 $606,000
Q3 2019 Nov 14, 2019	BUY	$19.51 - $24.28 $1,951 - $2,428	100 Added 0.34%	29,511 $576,000
Q2 2019 Aug 14, 2019	BUY	$21.47 - $37.33 $8,287 - $14,409	386 Added 1.33%	29,411 $663,000
Q1 2019 May 15, 2019	BUY	$28.4 - $36.49 $12,070 - $15,508	425 Added 1.49%	29,025 $1.06 Million
Q4 2018 Feb 08, 2019	BUY	$27.94 - $44.61 $2,794 - $4,461	100 Added 0.35%	28,600 $844,000
Q2 2018 Aug 10, 2018	BUY	$40.56 - $51.36 $8,112 - $10,272	200 Added 0.71%	28,500 $1.17 Million
Q4 2017 Feb 14, 2018	BUY	$47.69 - $55.39 $19,076 - $22,156	400 Added 1.43%	28,300 $1.55 Million
Q3 2017 Nov 13, 2017	BUY	$49.16 - $54.45 $1.37 Million - $1.52 Million	27,900	27,900 $1.42 Million

362

181M

175K

96.6K

Ticker ALKS
Exchange NASDAQ
Sector Healthcare
Industry Drug Manufacturers—Specialty & Generic
Shares Outstandng 164,254,000
Market Cap $4.9B
Description
Alkermes plc, a biopharmaceutical company, researches, develops, and commercializes pharmaceutical products to address unmet medical needs of patients in various therapeutic areas in the United States, Ireland, and internationally. Its marketed products include ARISTADA, an intramuscular injectable suspension for the treatment of schizophrenia; ...

Get notified when there are updates to the investment portfolio of Utah Retirement Systems, based on Form 13F filings with the SEC.

Stay updated on Utah Retirement Systems with notifications on news.